Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Năm xuất bản2012

Nguồn học thuậtNew England Journal of Medicine

Định danhDOI 10.1056/nejmoa1200694

TRÍCH DẪN ĐỀ XUẤTAPA 7

Julie R. Brahmer; Scott S. Tykodi; Laura Q.M. Chow; Wen-Jen Hwu; Suzanne L. Topalian; Patrick Hwu; Charles G. Drake; Luis H. Camacho; John Kauh; Kunle Odunsi; Henry C. Pitot; Omid Hamid; Shailender Bhatia; Renato Martins; Keith D. Eaton; Shuming Chen; Theresa M. Salay; Suresh Alaparthy; Joseph F. Grosso; Alan J. Korman; Susan Parker; Shruti Agrawal; S. Goldberg; Drew M. Pardoll; Ashok Gupta; Jon M. Wigginton (2012). Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer. New England Journal of Medicine, 366(26), 2455-2465. https://doi.org/10.1056/nejmoa1200694

Thông tin thư mục

Nguồn/Tạp chí: New England Journal of Medicine
Tập: 366
Số: 26
Trang: 2455-2465
Nhà xuất bản: Massachusetts Medical Society
DOI: 10.1056/nejmoa1200694 ↗

Từ khóa

Blockade; Immune system; PD-L1; Medicine; Antibody; In vitro; Cancer; Cancer research; Receptor; Immune checkpoint; Programmed cell death; Immunology; Function (biology); Cancer cell; Immunotherapy; Apoptosis; Cell biology; Biology; Internal medicine; Biochemistry